BCRX - BioCryst Pharmaceuticals Stock Trading

BioCryst Pharmaceuticals Inc.(NASDAQ: BCRX) stock trading, description, contact, officers and directors.

About BioCryst Pharmaceuticals Inc.

Not available

Stock Information

BioCryst Pharmaceuticals Inc. Company Name:

BCRX Stock Symbol:

NASDAQ Market:

BCRX - BioCryst Pharmaceuticals Stock Trading

Get BCRX Alerts

News, Short Squeeze, Breakout and More Instantly...

BCRX - BioCryst Appoints Vincent Milano to Board of Directors

RESEARCH TRIANGLE PARK, N.C., July 28, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed hereditary angioedema (HAE) and rare disease industry leader, Vincent Milano, to its board of directors. Mr. Milano currently...
BCRX - BioCryst to Report Second Quarter 2021 Financial Results on August 5

RESEARCH TRIANGLE PARK, N.C., July 22, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2021 financial results on Thursday, August 5, 2021. BioCryst management will host a conference call and web...
BCRX - BioCryst Announces Designs for REDEEM-1 and REDEEM-2 Pivotal Trials with BCX9930 as Oral Monotherapy for Patients with PNH

RESEARCH TRIANGLE PARK, N.C., July 15, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the designs for REDEEM-1 and REDEEM-2, two upcoming pivotal trials with its oral Factor D inhibitor, BCX9930, in patients with paroxysmal nocturnal hemoglobinuri...